SCHEMBL19397640

SCHEMBL19397640

c1ccc(-c2ccc(-c3cc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)nc(-c4cccnc4)n3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.49
▸ DHODH Q02127 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ CYP3A4 P08684 7/20 0.43
▸ CYP1A2 P05177 6/20 0.43
▸ CLK4 Q9HAZ1 6/20 0.43
▸ CYP2D6 P10635 4/20 0.43
▸ TSHR P16473 3/20 0.43
▸ CYP2C9 P11712 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853546 0.96 DHODH (0.50) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL17853486 0.96 DHODH (0.50) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL19397646 0.96 DHODH (0.50) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL17853693 0.96 DHODH (0.50) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL17853561 0.96 DHODH (0.50) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL17853564 0.96 DHODH (0.50) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL19275993 0.95 CYP19A1 (0.49) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL19397309 0.93 CYP19A1 (0.45) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL17853566 0.93 DHODH (0.47) CYP19A1DHODHALDH1A1HSD17B10MAPT
SCHEMBL17853607 0.92 DHODH (0.46) CYP19A1DHODHALDH1A1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 — — US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 — — US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM CYP19A1 515/4885DHODH 2746/4885ALDH1A1 129/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 CYP19A1 673/4885DHODH 3884/4885ALDH1A1 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback